Disease Management in Individuals with Phenylketonuria

Authors : Esra Gül, Ayşe Güneş Bayır

Pages : 572-581

Doi:10.33808/clinexphealthsci.1360624

View : 42 | Download : 79

Publication Date : 2024-06-28

Article Type : Review Paper

Abstract :Phenylketonuria (PKU), one of the most common metabolic diseases, is a recessive, congenital and hereditary disease that occurs with the absence or deficiency of the enzyme called phenylalanine hydroxylase, which converts phenylalanine to tyrosine. Therefore, the aim of this review was to discuss the disease management in individuals with phenylketonuria. As a result of the inability to metabolize phenylalanine amino acid in patients with PKU, the level of phenylalanine increases in the systemic circulation and brain, which may lead to neurocognitive activity and psychosocial dysfunctions and various disorders. If infants with PKU, who are indistinguishable from healthy babies at first birth, are fed like normal babies, phenylalanine accumulates in the body and symptoms occur and gradually worsen. To keep the blood sugar phenylalanine level at the desired range various medical treatment methods (pharmacological treatment and gene therapy), especially nutritional therapy, can be preferred. However, alternative treatment methods should be carried out in combination with diet therapy. Some dietary restrictions are maintained for life, while patients follow a strict diet in dietary protein intake to prevent high plasma phenylalanine levels and neurological damage. In this review, the definition, classification and phenylalanine-restricted diet treatments of phenylketonuria are discussed.
Keywords : Phenylketonuria, phenylalanine restriction, phenylalanine hycroxylase, enzyme deficiency, nutritional therapy